| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.061 | 0.3 |